Literature DB >> 22773347

Thoracoscopic pleural biopsy as an aid to diagnosis in pediatric tuberculosis with pleural involvement.

Charles Keys1, Elizabeth McLeod, Christopher Pesti, David Armstrong.   

Abstract

INTRODUCTION: Successful treatment of tuberculosis relies on microbiological diagnosis and drug sensitivities. Due to the pauci-bacillary nature of childhood infection, this is often not possible. We describe the successful microbiological diagnosis of tuberculosis using thoracoscopic pleural nodule biopsy.
MATERIAL AND METHODS: In seven patients presenting with pulmonary tuberculosis and pleural involvement, but in whom microbiological diagnosis could not be established, thoracoscopic pleural biopsy was performed and analyzed for histology, acid-fast bacilli, polymerase chain reaction (PCR), DNA, culture, and drug sensitivities.
RESULTS: In five out of the seven patients we achieved positive histology, culture, and drug sensitivities. In the remaining two patients, histology, PCR, and DNA probe were positive for tuberculosis.
CONCLUSIONS: Thoracoscopic pleural biopsy is a sensitive aid to the diagnosis of pleural tuberculosis in children. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22773347     DOI: 10.1055/s-0032-1315802

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  2 in total

1.  Utility of adenosine deaminase (ADA), PCR & thoracoscopy in differentiating tuberculous & non-tuberculous pleural effusion complicating chronic kidney disease.

Authors:  Sravan Kumar; Ritesh Agarwal; Amanjit Bal; Kusum Sharma; Navneet Singh; Ashutosh N Aggarwal; Indu Verma; Satyawati V Rana; Vivekanand Jha
Journal:  Indian J Med Res       Date:  2015-03       Impact factor: 2.375

Review 2.  Minimally invasive thoracic surgery in pediatric patients: the Taiwan experience.

Authors:  Yu-Kai Huang; Chieh Chou; Chung-Liang Li; Hui-Gin Chiu; Yu-Tang Chang
Journal:  Biomed Res Int       Date:  2013-05-30       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.